La prévention vaccinale contre la rage dans les pays en développement (état des lieux et pistes d'amélioration)

LYON1-BU Santé (693882101) / SudocSudocFranceF

Pathologie des voyages (transmission informatisée de conseils destinés aux praticiens)

LYON1-BU Santé (693882101) / SudocPARIS-BIUM (751062103) / SudocSudocFranceF

Pathologie des voyages (transmission informatisée de conseils destinés aux médecins praticiens)

LYON1-BU Santé (693882101) / SudocPARIS-BIUM (751062103) / SudocSudocFranceF

Evaluation in vivo de la chimiosensibilité de Plasmodium falciparum à la chloroquine dans la région de Moundou

En l'absence de données antérieures, la sensibilité de Plasmodium falciparum à la chloroquine à la dose de 25mglkg de poids per os en 3 jours, a été évaluée in vivo par une enquête efecfuée en Juin 1990, en début de saison des pluies, dans la ville de Moundou au sud du Tchad. 195 enfants ont éfé prélevés à l'école catholique deJeune fille et dans le quartier Djarabé, 28 enfants avec une parasitémie moyenne initiale de 1700 GRPlmm2 ont éfé suivie. Aucune résistance de type XII ou RlII n'a été mise en éuidence. La chloroquine doit donc rester le traitement présomptif de lfaccès palustre

Outcome of acute mesenteric ischemia in the intensive care unit: a retrospective, multicenter study of 780 cases

International audienc

Personal protection against biting insects and ticks.

International audienceRecent events with the first cases of local transmission of chikungunya and dengue fever virus in southern France by Aedes albopictus, adding to the nuisance and potential vectors that can be encountered when traveling in tropical or sub-tropical countries, has shown the value of a reflection on the Personal protection against vectors (PPAV). It is seen during an outbreak of vector-borne disease, or simply because of nuisance arthropods, that our fellow citizens try to protect themselves individually by using an arsenal of resources available on the market. Yet most of these means have been neither checked for effectiveness or safety tests, however, essential. Travellers, staff on mission or assignment, are looking for specific information on how to protect themselves or their families. Health workers had at their disposal so far indications that vary widely from one source to another. Therefore it seemed important to the Society of Travel Medicine (SMV) and the French Society of Parasitology (SFP) to initiate a reflection on this theme. This reflection took the form of recommendations for good practice, following the outline established by the French High Health Authority (HAS). The aim was to gather all relevant information, verified and validated and the format to be used not only by health personnel (doctors, pharmacists, nurses), but also by travel agents and individuals. This document highlights the need to take into account the risk of vector-borne diseases, some deadly, and the benefit of various methods of personal protection. The choice of methods is clearly oriented towards those whose effectiveness has been proven and potential risks assessed. The paper finally proposes two decision trees based on the transmission type (day or night) and kind of stay (short or roaming, long and steady). It concerns travellers, but also expatriates, residents and nomads